Skip to main content
    S

    Sabra Healthcare REIT Inc (SBRA)

    Official site

    REAL ESTATE • REIT - HEALTHCARE FACILITIES • NASDAQ

    $20.25
    -0.10 (-0.49%)

    Market Cap: $5.33B

    Last updated: Nov 17, 2026 at 4:32 PM ET

    Sabra Healthcare REIT Inc (SBRA) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Sabra Healthcare REIT (SBRA) has a market cap of $5.33B and a P/FFO of 12.1x on its 2026 FFO estimate. Its share count is up 6.55% from a year earlier. Its dividend yield is 5.93%.

    Total Valuation

    Enterprise value is 45.02% above the market cap, as debt exceeds cash.

    Market Cap$5.33B
    Enterprise Value$7.73B
    Latest price (Nov 17, 2026)$20.25

    Key Dates

    The next earnings report is expected on Feb 10, 2027, covering the quarter ending Dec 31, 2026. The last ex-dividend date was Nov 13, 2026.

    Next Earnings DateFeb 10, 2027 (expected)
    Last Earnings DateNov 2, 2026
    Last Ex-Dividend DateNov 13, 2026
    Next Payment DateNov 30, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 1.32% in the quarter ended Sep 30, 2026 and grew 4.45% a year over 2 years.

    Shares Outstanding255.60M
    Shares Change (YoY)+6.55%
    Shares Change (QoQ)+1.32%
    Share Count Growth (2Y CAGR)+4.45%

    Valuation Ratios

    P/FFO is 12.1x on the 2026 FFO estimate of $1.67 a share. Its year-end P/S ranged from 4.7x to 6.7x from 2016 to 2025.

    P/FFO (2026 estimate)12.1x
    Forward P/E40.2x
    P/S Ratio5.7x
    Forward P/S6.2x
    P/B Ratio1.8x
    P/TBV Ratio1.9x
    P/FCF Ratio15.1x
    P/OCF Ratio13.3x

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 27.1x EBITDA and 22.1x free cash flow.

    EV / Earnings108.5x
    EV / Sales8.5x
    EV / EBITDA27.1x
    EV / FCF22.1x

    Price Statistics

    The stock is up 13.60% over 52 weeks and trades 3.32% above its 50-day average.

    Beta (1Y)-0.12
    52-Week Change+13.60%
    1-Month Change+7.69%
    3-Month Change+0.04%
    6-Month Change-2.19%
    5-Year Change+39.51%
    10-Year Change-15.28%
    Total Return (1Y)+20.33%
    Total Return (3Y CAGR)+18.98%
    Total Return (5Y CAGR)+15.16%
    Return vs SPY (1Y)-0.72%
    Max Drawdown (1Y)-16.10%
    Max Drawdown (3Y)-16.80%
    Sharpe Ratio (1Y)0.42
    Correlation with SPY (1Y)-0.07
    50-Day Average$19.60
    200-Day Average$19.68
    52-Week Range$16.79 to $22.10
    RSI (14 Days)54.3
    Average Volume (20 Days)2.67M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Total debt is 0.86x shareholder equity.

    Debt / Equity0.86x
    Debt / EBITDA8.71x
    Debt / FCF7.12x
    Interest Coverage11.69x

    Returns and Efficiency

    Return on invested capital is 0.82% over the last 12 months, against a 5-year average of 1.09%.

    Return on Equity (ROE)2.51%
    Return on Assets (ROA)1.31%
    Return on Invested Capital (ROIC)0.82%
    ROE (5Y Average)0.95%
    ROA (5Y Average)0.45%
    ROIC (5Y Average)1.09%
    Asset Turnover0.17x

    Taxes

    Income tax took 2.72% of pretax income over the last 12 months.

    Income Tax (TTM)$1.77M
    Effective Tax Rate2.72%

    Scores

    SBRA has a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.

    Piotroski F-Score6 of 9
    Piotroski StrengthAverage

    Income Statement

    FFO per share was $1.54 for 2025, the latest reported year. Revenue of $912.36M over the last 12 months is up 19.51% from the 12 months before.

    FFO Per Share (2025)$1.54
    Revenue$912.36M
    Revenue Growth (YoY)+19.51%
    Pretax Income$65.02M
    Net Income$71.27M
    EBITDA$279.59M

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 52.30% of the $5.43B in total assets.

    Cash and Equivalents$36.24M
    Total Debt$2.44B
    Net Debt$2.40B
    Net Debt Per Share$9.39
    Shareholder Equity$2.84B
    Book Value Per Share$11.11
    Tangible Book Value$2.75B
    Tangible Book Per Share$10.77
    Total Assets$5.43B
    Total Liabilities$2.59B

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $58.40M of capital spending, operating cash flow left $342.18M of free cash flow.

    Operating Cash Flow$400.58M
    Capital Expenditures$58.40M
    Free Cash Flow$342.18M
    FCF Per Share$1.34
    Depreciation and Amortization$235.17M
    Dividends Paid$302.76M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    Pretax Margin7.13%
    Net Margin7.81%
    EBITDA Margin30.65%
    FCF Margin37.51%
    Gross Margin (5Y Average)77.69%
    Operating Margin (5Y Average)39.54%
    Net Margin (5Y Average)-0.22%

    Growth

    FFO per share fell 0.64% a year over 3 years, and revenue grew 15.00% a year.

    FFO Per Share Growth (3Y CAGR)-0.64%
    Revenue Growth (3Y CAGR)+15.00%
    Revenue Growth (5Y CAGR)+6.07%
    FCF Growth (3Y CAGR)+5.54%
    FCF Growth (5Y CAGR)-0.03%
    Operating Income Growth (3Y CAGR)+3.96%
    Book Value Per Share Growth (2Y CAGR)-3.62%
    Tangible Book Per Share Growth (2Y CAGR)-4.21%

    Revenue and profit by year

    Dividends and Yields

    SBRA pays out 77.92% of 2025 FFO as dividends.

    Dividend Per Share (Annual)$1.20
    Dividend Yield5.93%
    Payment ScheduleQuarterly
    Dividend Growth (3Y CAGR)0.00%
    Dividend Growth (5Y CAGR)-2.33%
    Payout Ratio (2025 FFO)77.92%
    FCF Payout Ratio88.48%
    FFO Yield (2025)7.60%
    FCF Yield6.61%
    Buyback Yield-3.92%
    Shareholder Yield1.93%

    Full dividend history

    Stock Splits

    The last split was a 1-for-3 reverse split on Nov 16, 2010.

    Last Split DateNov 16, 2010
    Split TypeReverse split
    Split Ratio1:3

    Peer Position

    Against 12 similar companies, SBRA has the 6th highest P/FFO and the 7th highest P/S.

    P/FFO12.1x vs 11.7x median
    P/S Ratio5.7x vs 5.5x median
    ROIC0.82% vs 3.37% median
    Revenue Growth (Trailing 4 Quarters, YoY)+19.51% vs +10.13% median
    Dividend Yield5.93% vs 5.31% median

    Competitors compared

    Analyst Forecast

    FFO per share estimates imply 5.38% growth a year over the next 2 years. Consensus estimates put revenue growth at 12.57% a year over the next 2 fiscal years.

    FFO Per Share Growth Forecast (2Y CAGR)+5.38%
    Revenue Growth Forecast (2Y CAGR)+12.57%
    EPS Growth Forecast (2Y CAGR)-14.19%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About SBRA

    What is SBRA's market cap?

    Sabra Healthcare REIT has a market cap of $5.33B. Its enterprise value, which adds debt and subtracts cash, is $7.73B.

    What is SBRA's price to FFO ratio?

    Sabra Healthcare REIT has a P/FFO of 12.1x on its 2026 FFO estimate.

    How many shares of SBRA are outstanding?

    Sabra Healthcare REIT has 255.60M shares outstanding. The count is up 6.55% from a year earlier.

    Does SBRA pay a dividend?

    Yes. Sabra Healthcare REIT pays $1.20 a share a year, a dividend yield of 5.93%.

    How much debt does SBRA have?

    Sabra Healthcare REIT has $2.44B of total debt and $36.24M of cash and equivalents, a net debt position of $2.40B.